Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care (NCT04838210)
🩺 Plain-English Summary (8th-Grade Level)
This study will provide high-quality, representative data on the capacity of Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care (EleVATE GC) to reduce perinatal depression, preterm birth, and low birthweight in African-American women. If findings from this study indicate that EleVATE GC is feasible and effective, this model could be implemented nationwide to help achieve mental and obstetric health parity for low-income women of color in the United States.
Who can join: Review the eligibility criteria below.
Location: University of Missouri-Kansas City/Truman Health Centers-Kansas City — Kansas City, Missouri
Age range: 13 Years
🧪 Interventions in This Study
- EleVATE Group Care (BEHAVIORAL)
- Individual Prenatal Care (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- University of Missouri-Kansas City/Truman Health Centers-Kansas City — Kansas City, Missouri
- Affinia Healthcare — St Louis, Missouri
- Family Care Health Centers — St Louis, Missouri
- CareSTL Health — St Louis, Missouri
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pregnancy Related
- Natural Versus Programmed Frozen Embryo Transfer (NatPro) — San Francisco, California
- Prospective Study of Pregnancy in Women With Cystic Fibrosis — Birmingham, Alabama
- Maternal & Offspring Microbiome Study — Stanford, California
- Well-Mama Community Doula Navigator Study — Baton Rouge, Louisiana
- MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy — Marlborough, Massachusetts
Explore by condition: All Pregnancy Related clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.